This article was originally published in The Gray Sheet
Sale of mercury-containing blood pressure devices will be prohibited beginning in 2006 under laws passed in Maine and Washington on May 19 and May 14, respectively. The states are the first to ban certain mercury-containing products, according to watchdog group Health Care Without Harm. On a national level, HCWH says it has worked with Premier and Consorta to phase out GPO contracts covering mercury-containing devices such as blood pressure monitors, thermometers and balloon GI dilators...
You may also be interested in...
The addition of the question “Was this device serviced by a third party servicer?” to adverse event reports filed through the US FDA’s electronic Medical Device Reporting system could prove helpful for the agency and device makers, experts tell Medtech Insight. Industry has long complained about poor work performed by servicers – and loudly groused that they’re not regulated.
Attorneys tell Medtech Insight a recent proposal to review regulations every 10 years could lift some burdens from the medical device industry, but warned that the full effects may not be seen for some time.
A nasal spray formulated using compounds already approved by regulatory bodies in Europe and the US can “prevent and slow” transmission of COVID-19, according to UK researchers who are now seeking a partner to commercialize the product.